NIH Awards $57.5 Million to Boston University’s National Emerging Infectious Diseases Laboratories
Five-year grant will help support mission to protect Americans and people around the world from major health threats.
Renowned Virologist Robert A. Davey to Lead NEIDL, BU’s Infectious Diseases Research Hub
An expert on virus-host interactions and antiviral drug discovery, Davey says NEIDL will continue to focus on conducting “creative, inventive science in the safest ways possible”.
Nancy J. Sullivan, Ebola Vaccine and Treatment Pioneer, Named New NEIDL Director
Says priorities will include global engagement, strong science, and diversity, equity, and inclusion.